Facets (new session)
Description
Metadata
Settings
owl:sameAs
Inference Rule:
b3s
b3sifp
dbprdf-label
facets
http://dbpedia.org/resource/inference/rules/dbpedia#
http://dbpedia.org/resource/inference/rules/opencyc#
http://dbpedia.org/resource/inference/rules/umbel#
http://dbpedia.org/resource/inference/rules/yago#
http://dbpedia.org/schema/property_rules#
http://www.ontologyportal.org/inference/rules/SUMO#
http://www.ontologyportal.org/inference/rules/WordNet#
http://www.w3.org/2002/07/owl#
ldp
oplweb
skos-trans
virtrdf-label
None
About:
Nebulisation of synthetic lamellar lipids mitigates radiation-induced lung injury in a large animal model
Goto
Sponge
NotDistinct
Permalink
An Entity of Type :
schema:ScholarlyArticle
, within Data Space :
covidontheweb.inria.fr
associated with source
document(s)
Type:
Academic Article
research paper
schema:ScholarlyArticle
New Facet based on Instances of this Class
Attributes
Values
type
Academic Article
research paper
schema:ScholarlyArticle
isDefinedBy
Covid-on-the-Web dataset
has title
Nebulisation of synthetic lamellar lipids mitigates radiation-induced lung injury in a large animal model
Creator
Schwarz, Tobias
Collie, David
Del-Pozo, Jorge
Howard, Lynsey
Kay, Elaine
Lawrence, Jessica
Mclachlan, Gerry
Mclean, Alec
Murchison, John
Parys, Magdalena
Smith, Sionagh
Wright, Steven
Source
PMC
abstract
Methods to protect against radiation-induced lung injury (RILI) will facilitate the development of more effective radio-therapeutic protocols for lung cancer and may provide the means to protect the wider population in the event of a deliberate or accidental nuclear or radiological event. We hypothesised that supplementing lipid membranes through nebulization of synthetic lamellar lipids would mitigate RILI. Following pre-treatment with either nebulised lamellar lipids or saline, anaesthetised sheep were prescribed fractionated radiotherapy (30 Gray (Gy) total dose in five 6 Gy fractions at 3–4 days intervals) to a defined unilateral lung volume. Gross pathology in radio-exposed lung 37 days after the first radiation treatment was consistent between treatment groups and consisted of deep red congestion evident on the pleural surface and firmness on palpation. Consistent histopathological features in radio-exposed lung were subpleural, periarteriolar and peribronchial intra-alveolar oedema, alveolar fibrosis, interstitial pneumonia and type II pneumocyte hyperplasia. The synthetic lamellar lipids abrogated radiation-induced alveolar fibrosis and reduced alpha-smooth muscle actin (ASMA) expression in radio-exposed lung compared to saline treated sheep. Administration of synthetic lamellar lipids was also associated with an increased number of cells expressing dendritic cell-lysosomal associated membrane protein throughout the lung.
has issue date
2018-09-06
(
xsd:dateTime
)
bibo:doi
10.1038/s41598-018-31559-3
bibo:pmid
30190567
has license
cc-by
sha1sum (hex)
05de65a45721a53c9704160d40571cce2cf1e866
schema:url
https://doi.org/10.1038/s41598-018-31559-3
resource representing a document's title
Nebulisation of synthetic lamellar lipids mitigates radiation-induced lung injury in a large animal model
has PubMed Central identifier
PMC6127301
has PubMed identifier
30190567
schema:publication
Sci Rep
resource representing a document's body
covid:05de65a45721a53c9704160d40571cce2cf1e866#body_text
is
schema:about
of
named entity 'FIRMNESS'
named entity 'UNILATERAL LUNG'
named entity 'FEATURES'
named entity 'MEMBRANE PROTEIN'
named entity 'ASSOCIATED'
named entity 'EXPOSED'
named entity 'DEEP'
named entity 'GRAY'
named entity 'SALINE'
named entity 'PROTOCOLS'
named entity 'ALVEOLAR'
named entity 'SUBPLEURAL'
named entity 'alveolar'
named entity 'interstitial pneumonia'
named entity 'nebulization'
named entity 'fibrosis'
named entity 'membrane protein'
named entity 'subpleural'
named entity 'radiation treatment'
named entity 'pleural'
named entity 'saline'
named entity 'lipids'
named entity 'palpation'
named entity '37 days'
named entity 'lung'
named entity 'anaesthetised'
named entity 'Heatmap'
named entity 'hyperplasia'
named entity 'TGFbeta'
named entity 'ImageJ'
named entity 'Sheep'
named entity 'Alveolar'
named entity 'Qiagen'
named entity 'interstitial pneumonia'
named entity 'collagen'
named entity 'staining'
named entity 'lung tissue'
named entity 'contralateral'
named entity 'mesenchymal'
named entity 'Histopathology'
named entity 'cytoplasm'
named entity 'lung fibrosis'
named entity 'PTV'
named entity 'pathology'
named entity 'lungs'
named entity 'interstitium'
named entity 'contralateral'
named entity 'nucleus'
named entity 'radiation exposure'
named entity 'maedi'
named entity 'macrophages'
named entity 'TGF-β'
named entity 'fibrosis'
named entity 'ground substance'
named entity 'pathologist'
named entity 'macrophages'
named entity 'statistically significant'
named entity 'fibrosis'
named entity 'TGF-β1'
named entity 'type II pneumocyte'
named entity 'visna virus'
named entity 'smooth muscle cells'
named entity 'scavenges'
named entity 'medical waste'
named entity 'BALF'
named entity 'membrane protein'
named entity 'hyperplasia'
named entity 'necropsy'
named entity 'interstitium'
named entity 'type II pneumocyte'
◂◂ First
◂ Prev
Next ▸
Last ▸▸
Page 1 of 10
Go
Faceted Search & Find service v1.13.91 as of Mar 24 2020
Alternative Linked Data Documents:
Sponger
|
ODE
Content Formats:
RDF
ODATA
Microdata
About
OpenLink Virtuoso
version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software